NCT01557010View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Postherpetic Neuralgia
Interventions
DRUG

DWP05195

Tablets, oral administration, 100mg

DRUG

DWP05195

Tablets, oral administration, 200mg

DRUG

DWP05195

Tablets, oral administration, 300mg

DRUG

Control

Tablets, oral administration, Placebo

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY